fda

Alcohol-Associated Liver Disease Mortality Increased During, After COVID-19 Pandemic

by

Alcohol-Associated Liver Disease: Trends and Projections for the Future The landscape of liver health is constantly evolving, and recent studies have highlighted significant shifts in mortality rates related to Alcohol-Associated Liver Disease (ALD). Understanding these trends is crucial for public health professionals, healthcare providers, and individuals alike. This article delves into the latest findings, explores … Read more

Bangkok Post – Police doctor arrested with B15m worth of sedatives

by

The Shadowy Side of Pharmaceuticals: Future Trends in Drug Diversion and Abuse The recent arrest of a police doctor in Thailand, accused of illegally procuring and distributing alprazolam, shines a harsh light on the ongoing challenges of pharmaceutical drug diversion and abuse. This case, involving the misuse of a widely prescribed sedative, underscores the need … Read more

Obicetrapib Reduces HbA1c, New-Onset Diabetes Risk in ASCVD, HeFH

by

Obicetrapib and the Future of Lipid Management: A New Horizon for Cardiovascular Health The world of cardiovascular medicine is constantly evolving, and recent research on obicetrapib offers a compelling glimpse into the future of treating heart disease. This emerging therapy, a highly specific cholesteryl ester transfer protein (CETP) inhibitor, is showing promise in reducing LDL-C … Read more

Lupus Nephritis Studies Spotlight Impact of Fatigue, Disease Activity on QoL, with Sayna Norouzi, MD

by

Beyond the Lab: Unveiling the Real-World Impact of Lupus Nephritis For years, the focus in lupus nephritis (LN) has been primarily on clinical markers – kidney function, proteinuria, and disease activity scores. However, two recent studies presented at the European Renal Association (ERA) Congress 2025, shed light on a critical, often overlooked, dimension: the patient … Read more

California Urges FDA to Lift Mifepristone Restrictions Amid RFK Jr. Concerns

by

Mifepristone Access: A Shifting Landscape in Reproductive Healthcare The debate surrounding mifepristone, the abortion pill, continues to intensify, with legal challenges, political maneuvering, and scientific scrutiny shaping its availability. This article delves into the core issues and potential future trends surrounding access to this critical medication. The Core of the Controversy: Safety and Access At … Read more

Transfusion Strategies Show No QOL Improvement in Anemia Patients

by

Transfusion Strategies and Quality of Life After Heart Attacks: What’s Next? As a seasoned health journalist, I’ve seen firsthand the evolution of cardiac care. Recent research, like the secondary analysis of the Myocardial Ischemia and Transfusion (MINT) trial, sheds light on the crucial relationship between blood transfusion strategies, particularly in patients with myocardial infarction (MI), … Read more

Omaha mom fears son could lose access to drug

by

A Race Against Time: The Fight for Life-Saving Drugs in Rare Disease Cases The recent news from Omaha, Nebraska, highlights a critical issue in modern medicine: the urgent need for expedited drug approvals for rare diseases. When a medication shows promise in saving lives, the bureaucratic hurdles can feel like a cruel twist of fate. … Read more

Subtle Differences Emerge Between FDA And CDC On COVID Vaccine Advice

by

COVID-19 Vaccines: Navigating a New Era of Guidance and Eligibility The landscape of COVID-19 vaccination is shifting, moving from a broad-based approach to a more targeted one. This evolution reflects a deeper understanding of the virus and the evolving needs of the population. Understanding these changes is crucial for staying informed and making the right … Read more

FDA Approves Acoltremon for Dry Eye Disease

by

New Hope for Dry Eye Sufferers: Exploring the Future of Treatment Dry eye disease (DED) affects millions, causing discomfort and impacting daily activities. A new treatment, acoltremon ophthalmic solution 0.003% (Tryptyr), offers a novel approach. Let’s delve into the evolving landscape of DED treatments and explore what the future holds. Understanding the Dry Eye Dilemma … Read more

Quadrivalent Meningococcal Vaccine Receives FDA Approval for Infants and Children With Meningococcal Disease

by

New Horizons in Meningococcal Disease Prevention: What’s Next? The recent FDA approval of an expanded indication for the quadrivalent meningococcal vaccine (MenQuadfi) marks a significant step forward in protecting vulnerable populations from invasive meningococcal disease. This approval, extending coverage to infants as young as 6 weeks old, opens exciting avenues for preventative care. But what … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]